News Release

SAN DIEGO--(BUSINESS WIRE)--Aug. 29, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will be attending the following upcoming investor conferences:

• Baird Global Healthcare Conference on Wednesday, September 4, 2019 in New York City, including a presentation by Kim Blickenstaff, executive chairman, at 12:15pm Eastern Time (9:15am Pacific Time),
• Dougherty & Company Institutional Investor Conference on Thursday, September 5, 2019 in Minneapolis,
• Morgan Stanley Healthcare Conference on Wednesday, September 11, 2019 in New York City, including a presentation by John Sheridan, president and chief executive officer, at 10:30am Eastern Time (7:30am Pacific Time), and
• Lake Street Best Ideas Growth Conference on Thursday, September 12, 2019 in New York City.

The Company update presentations will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem’s flagship product, the t:slim X2™ insulin pump, is capable of remote software updates using a personal computer and features integrated continuous glucose monitoring. Tandem is based in San Diego, California.

Tandem Diabetes Care is a registered trademark and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2, and $TNDM.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190829005690/en/

Source: Tandem Diabetes Care, Inc.

Media Contact:
Steve Sabicer
714-907-6264
ssabicer@thesabicergroup.com

Investor Contact:
Susan Morrison
858-366-6900 x7005
IR@tandemdiabetes.com